Literature DB >> 2295471

Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients.

N Rolando1, F Harvey, J Brahm, J Philpott-Howard, G Alexander, A Gimson, M Casewell, E Fagan, R Williams.   

Abstract

Fifty consecutive patients admitted with acute liver failure, minimal grade II encephalopathy, were studied prospectively to determine the incidence, timing and cause of bacterial infection, the relationship to clinical criteria for infection; and the influence of early microbiological diagnosis on clinical outcome. There were 53 proven bacterial infections in 40 patients, whereas in 5 of the remaining 10 patients infection was suspected on clinical grounds in the absence of significant cultures. Seven patients (14%) had more than one bacterial infection, and four patients had simultaneous infections caused by different organisms at each site. Fourteen infections (26.4%) were associated with bacteremia, and in six of these no source was found. Twenty-five infections (47.1%) arose from the respiratory tract, 12 (22.6%) from the urinary tract and 2 (3.7%) from central venous cannulas. Thirty-seven (69.8%) of the 53 infections were due to gram-positive bacteria; Staphylococcus aureus accounted for 19 (35.8%) of all the infections. Thirty patients died (60%), 28 of whom had bacterial infection at some time; in 24 of these the infection was diagnosed less than 24 hr before death. All nine deaths that occurred more than 7 days after admission were directly attributable to microbial infection. Clinical features such as elevated temperature and elevated peripheral white blood cell count were poor indicators of bacterial infection because these were absent in 30.2% of cases. These data show that there is a high incidence of bacterial infection early in the course of acute liver failure and suggest that prophylactic antimicrobial therapy, although unproven, might be justified.

Entities:  

Mesh:

Year:  1990        PMID: 2295471     DOI: 10.1002/hep.1840110110

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  56 in total

Review 1.  Translational systems approaches to the biology of inflammation and healing.

Authors:  Yoram Vodovotz; Gregory Constantine; James Faeder; Qi Mi; Jonathan Rubin; John Bartels; Joydeep Sarkar; Robert H Squires; David O Okonkwo; Jörg Gerlach; Ruben Zamora; Shirley Luckhart; Bard Ermentrout; Gary An
Journal:  Immunopharmacol Immunotoxicol       Date:  2010-06       Impact factor: 2.730

2.  Severe bacteremia results in a loss of hepatic bacterial clearance.

Authors:  Alix Ashare; Martha M Monick; Linda S Powers; Timur Yarovinsky; Gary W Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2006-01-06       Impact factor: 21.405

Review 3.  Hepatology.

Authors:  P M Harrison; J Y Lau; R Williams
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

Review 4.  Pathogenesis of ascites and hepatorenal syndrome.

Authors:  S P Wilkinson; K P Moore; V Arroyo
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 5.  Infections.

Authors:  N Rolando; R J Wyke
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 6.  Liver regeneration in relationship to acute liver failure.

Authors:  C D Gove; R D Hughes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

Review 7.  Acute liver failure.

Authors:  R D Hughes; J Wendon; A E Gimson
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Shiv Kumar Sarin; Ashish Kumar; John A Almeida; Yogesh Kumar Chawla; Sheung Tat Fan; Hitendra Garg; H Janaka de Silva; Saeed Sadiq Hamid; Rajiv Jalan; Piyawat Komolmit; George K Lau; Qing Liu; Kaushal Madan; Rosmawati Mohamed; Qin Ning; Salimur Rahman; Archana Rastogi; Stephen M Riordan; Puja Sakhuja; Didier Samuel; Samir Shah; Barjesh Chander Sharma; Praveen Sharma; Yasuhiro Takikawa; Babu Ram Thapa; Chun-Tao Wai; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2008-11-20       Impact factor: 6.047

9.  TGR5 signaling reduces neuroinflammation during hepatic encephalopathy.

Authors:  Matthew McMillin; Gabriel Frampton; Richard Tobin; Giuseppina Dusio; Jenny Smith; Hope Shin; Karen Newell-Rogers; Stephanie Grant; Sharon DeMorrow
Journal:  J Neurochem       Date:  2015-09-10       Impact factor: 5.372

Review 10.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.